ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 62 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,949,000 | -39.1% | 2,026,656 | 0.0% | 0.26% | -31.2% |
| Q1 2022 | $93,510,000 | -47.5% | 2,026,656 | -4.3% | 0.38% | -26.3% |
| Q4 2021 | $178,063,000 | +26.1% | 2,118,284 | 0.0% | 0.51% | +32.6% |
| Q3 2021 | $141,162,000 | +10.6% | 2,118,284 | -11.7% | 0.39% | 0.0% |
| Q2 2021 | $127,642,000 | +22.6% | 2,399,284 | 0.0% | 0.39% | +24.8% |
| Q1 2021 | $104,105,000 | -33.4% | 2,399,284 | -20.3% | 0.31% | -27.9% |
| Q4 2020 | $156,406,000 | +7.7% | 3,011,284 | -32.2% | 0.43% | -18.1% |
| Q3 2020 | $145,251,000 | -31.9% | 4,443,284 | 0.0% | 0.52% | -43.1% |
| Q2 2020 | $213,366,000 | – | 4,443,284 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |